This week's highest-impact publications across 29 specialties, curated by AI
Last updated: 22 de mai. de 2026
Published: 2026-07-01
Molecular medicine reports
MediLens Indexed: 2026-05-23
This review discusses the challenges of radioresistance in lung cancer management, highlighting its role in therapeutic failure and increased mortality. It emphasizes the need for a deeper understanding of the molecular mechanisms driving radioresistance, which could lead to the identification of...
Read on PubMedPublished: 2026-07-01
International journal of molecular medicine
MediLens Indexed: 2026-05-23
The study explores the therapeutic effects of Ginsenoside Rg3 in combination with cisplatin on lung carcinoma cells, addressing the limitations of cisplatin due to nephrotoxicity and drug resistance.
Read on PubMedPublished: 2026-06-01
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
MediLens Indexed: 2026-05-23
Lung cancer continues to be the leading cause of cancer-related deaths globally, with a notable increase in cases among never-smokers, particularly in East Asian women. This review emphasizes the need for a shift in lung cancer screening strategies, advocating for comprehensive computed tomograph...
Read on PubMedPublished: 2026-05-26
Proceedings of the National Academy of Sciences of the United States of America
MediLens Indexed: 2026-05-23
This study explores the role of the glucocorticoid receptor in cancer cell dormancy and proposes a novel approach using photoPROTACs for targeted modulation of GR degradation. The findings suggest potential advancements in overcoming therapy resistance in non-lymphoid solid tumors, particularly l...
Read on PubMedPublished: 2026-05-22
Clinical transplantation and research
MediLens Indexed: 2026-05-23
This study evaluates liver transplantation outcomes at Changwon Hanmaeum Hospital over a 2.5-year period, highlighting the importance of institutional experience in optimizing results. A total of 56 liver transplants were performed, with 82.1% of patients surviving to discharge. Notably, outcomes...
Read on PubMedJoin physicians worldwide who start their morning with AI-curated literature reviews, delivered to your inbox at 7 AM.
Start 14-Day Free Trial